Drug recall · March 12, 2014
Bupivacaine HCl Inj. USP recall
Why: Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1162-02
- Lots / codes
Lot 25-097-DK; Exp 01/01/2015
- Quantity
- 115,500 Vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- February 10, 2014 · Voluntary: Firm initiated
- Classified
- March 5, 2014
- Reported
- March 12, 2014
- Ended
- February 1, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.